Almac Contract Development and Manufacturing Organization

Almac Group is an established, leading contract development and manufacturing organisation providing an extensive range of integrated services to over 600 pharmaceutical and biotech companies globally. Its comprehensive solutions range from R&D, biomarker discovery and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture. The privately owned, global organisation has grown organically over 45 years now employing almost 5,000 highly skilled personnel and has a strong reputation for innovation, quality and exceptional customer service.  The Group is headquartered in Craigavon, Northern Ireland with additional operations based throughout Europe, US and Asia.

Almac Clinical Services

Almac Clinical Services is one of five business units within the Almac Group which has over 30 years’ experience delivering a full range of innovative clinical trial supply and technology solutions to pharmaceutical and biotech companies worldwide. They are the most trusted and stable name in the clinical supply marketplace.

Headquartered in Craigavon, Northern Ireland – with US operations based in Durham, North Carolina and Souderton, Pennsylvania, in addition to a facility in Singapore and Japan – Clinical Services champions integrated clinical supply and technological excellence to make their customers’ clinical trials more effective and efficient. They work with all types of companies, from virtual and biotech, to multi-national pharmaceutical companies.

Services Include:

  • COMPARATOR SOURCING & BLINDING
  • PACKAGING & LABELLING
  • ANALYTICAL SERVICES
  • QUALIFIED PERSON SERVICES (QP)
  • GLOBAL DISTRIBUTION & DEPOT NETWORK
  • NEXT GENERATION TEMPERATURE MANAGEMENT
  • SUPPLY CHAIN MANAGEMENT

 

Contact Details

Email: info@almacgroup.com

Website: www.almacgroup.com/clinical-services

Phone: +44 (0)28 3833 2200

Make an enquiry

Press Release

Almac Clinical Technologies Introduces Simplify™, an Advanced IRT Solution Enabling Faster Clinical Trials Start-up

Almac Clinical Technologies, part of the Almac Group, today announced the availability of Simplify™, a next-generation Interactive Response Technology (IRT) solution that comes standard with an array of configurable functionality designed to accelerate the study start-up process with greater efficiency.

Address

Almac Images

Products and Services

Video

White Papers

Related Projects



Press Release

5th June 2020

Almac Clinical Technologies, part of the Almac Group, today announced the availability of Simplify™, a next-generation Interactive Response Technology (IRT) solution that comes standard with an array of configurable functionality designed to accelerate the study start-up process with greater efficiency.

Read more
1st June 2020

Almac Clinical Technologies has announced the expedited deployment and support of multiple Interactive Response Technology (IRT) solutions in support of Covid-19 therapies.

Read more

Regional Offices

Close
Close
Close

Go Top